{"id":"NCT00948428","sponsor":"Actavis Inc.","briefTitle":"Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis","officialTitle":"A Multicenter, Double-Blind, Randomized, Parallel Group, Vehicle-Controlled Study to Determine the Clinical Equivalence of a Generic Imiquimod Cream, 5% and Aldara™ Cream in Subjects With Actinic Keratosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-05","primaryCompletion":"2009-03","completion":"2009-04","firstPosted":"2009-07-29","resultsPosted":"2020-09-04","lastUpdate":"2020-09-04"},"enrollment":462,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Actinic Keratoses"],"interventions":[{"type":"DRUG","name":"imiquimod","otherNames":[]},{"type":"DRUG","name":"Aldara™","otherNames":[]},{"type":"DRUG","name":"Vehicle Cream","otherNames":[]}],"arms":[{"label":"Generic Imiquimod","type":"ACTIVE_COMPARATOR"},{"label":"Aldara™","type":"ACTIVE_COMPARATOR"},{"label":"Vehicle cream","type":"PLACEBO_COMPARATOR"}],"summary":"At the end of the study, safety and efficacy outcome measures will be compared to determine a) if dosing with Generic Imiquimod cream, 5% is therapeutically equivalent to the currently marketed Aldara (imiquimod) cream, 5% and b) if both imiquimod 5% creams are superior in comparison to the Vehicle cream.","primaryOutcome":{"measure":"Percentage of Subjects in Each Treatment Group With Complete Clearance of AK Lesions at the Test of Cure Visit (Week 24)","timeFrame":"Week 24","effectByArm":[{"arm":"Generic Imiquimod","deltaMin":74,"sd":null},{"arm":"Aldara™","deltaMin":72,"sd":null},{"arm":"Vehicle Cream","deltaMin":7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG002","p":"0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":8},"locations":{"siteCount":20,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":181},"commonTop":["Nasopharyngitis","Headache","Basal cell carcinoma","Squamous cell carcinoma of skin","Nausea"]}}